| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 260, Issue 4 817-R823, Copyright © 1991 by American Physiological Society
ARTICLES |
M. D. Esler, G. Wallin, P. K. Dorward, G. Eisenhofer, R. Westerman, I. Meredith, G. Lambert, H. S. Cox and G. Jennings
Baker Medical Research Institute, Prahran, Victoria, Australia.
In isolated organs, or when given in low dose intra-arterially, tricyclic antidepressant drugs are known to block reuptake of norepinephrine into sympathetic nerve varicosities, with a resultant increased norepinephrine washout. On the other hand, systemic administration of such drugs in humans reduces norepinephrine spillover to plasma. To clarify these seemingly contradictory findings, we have measured concurrently muscle sympathetic activity in the peroneal nerve (microneurography) and rates of norepinephrine spillover to plasma for the body as a whole and for the heart, the kidneys, and the forearm (radiotracer technique), both before and after intravenous infusion of desipramine, 0.5 mg/kg. Desipramine lowered the overflow of norepinephrine to plasma for the body as a whole and from the forearm and the kidneys (by 30-50%) but increased cardiac norepinephrine spillover by 25%. Both the number of sympathetic bursts per min in the peroneal nerve and their mean voltage amplitudes were markedly reduced after desipramine; total activity (bursts/min x mean burst amplitude) fell by approximately 90%. The effects of desipramine on norepinephrine spillover are explicable in terms of inhibition of central sympathetic outflow, balanced against the local blockade of transmitter reuptake. In most sites, the predominant effect is a reduction of norepinephrine overflow. For the heart, where reuptake is so important in transmitter disposition, the net effect is increased overflow.
This article has been cited by other articles:
|
|
 |
|
  S. Strempel, C. Schroeder, R. Hemmersbach, A. Boese, J. Tank, A. Diedrich, M. Heer, F. C. Luft, and J. Jordan Norepinephrine transporter inhibition alters the hemodynamic response to hypergravitation J Appl Physiol, March 1, 2008; 104(3): 756 - 760. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. H. H. Leenen, A. Fourney, E. Coletta, and R. White Effects of hypertension on cardiovascular responses to epinephrine in humans Am J Physiol Heart Circ Physiol, June 1, 2007; 292(6): H3025 - H3031. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. H. H. Leenen, E. Coletta, A. Fourney, and R. White Aging and cardiac responses to epinephrine in humans: role of neuronal uptake Am J Physiol Heart Circ Physiol, May 1, 2005; 288(5): H2498 - H2503. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schroeder, F. Adams, M. Boschmann, J. Tank, S. Haertter, A. Diedrich, I. Biaggioni, F. C. Luft, and J. Jordan Phenotypical evidence for a gender difference in cardiac norepinephrine transporter function Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2004; 286(5): R851 - R856. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. O. Mundinger, Q. Mei, D. P. Figlewicz, A. Lernmark, and G. J. Taborsky Jr Impaired glucagon response to sympathetic nerve stimulation in the BB diabetic rat: effect of early sympathetic islet neuropathy Am J Physiol Endocrinol Metab, November 1, 2003; 285(5): E1047 - E1054. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C.-s. Liang, A. Yatani, Y. Himura, M. Kashiki, and S. Y. Stevens Desipramine attenuates loss of cardiac sympathetic neurotransmitters produced by congestive heart failure and NE infusion Am J Physiol Heart Circ Physiol, May 1, 2003; 284(5): H1729 - H1736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. J. Tack, P. J. van Gurp, C. Holmes, and D. S. Goldstein Local Sympathetic Denervation in Painful Diabetic Neuropathy Diabetes, December 1, 2002; 51(12): 3545 - 3553. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Schroeder, J. Tank, M. Boschmann, A. Diedrich, A. M. Sharma, I. Biaggioni, F. C. Luft, and J. Jordan Selective Norepinephrine Reuptake Inhibition as a Human Model of Orthostatic Intolerance Circulation, January 22, 2002; 105(3): 347 - 353. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Q. Mei, T. O. Mundinger, D. Kung, D. G. Baskin, and G. J. Taborsky Jr. Fos expression in rat celiac ganglion: an index of the activation of postganglionic sympathetic nerves Am J Physiol Endocrinol Metab, October 1, 2001; 281(4): E655 - E664. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Xu, G. D. Fink, A. Chen, S. Watts, and J. J. Galligan Nitric oxide-independent effects of tempol on sympathetic nerve activity and blood pressure in normotensive rats Am J Physiol Heart Circ Physiol, August 1, 2001; 281(2): H975 - H980. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Rumantir, D. M. Kaye, G. L. Jennings, M. Vaz, J. A. Hastings, and M. D. Esler Phenotypic Evidence of Faulty Neuronal Norepinephrine Reuptake in Essential Hypertension Hypertension, November 1, 2000; 36(5): 824 - 829. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Bertram, C. Barres, Y. Cheng, and C. Julien Norepinephrine reuptake, baroreflex dynamics, and arterial pressure variability in rats Am J Physiol Regulatory Integrative Comp Physiol, October 1, 2000; 279(4): R1257 - R1267. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. R. Shannon, N. L. Flattem, J. Jordan, G. Jacob, B. K. Black, I. Biaggioni, R. D. Blakely, and D. Robertson Orthostatic Intolerance and Tachycardia Associated with Norepinephrine-Transporter Deficiency N. Engl. J. Med., February 24, 2000; 342(8): 541 - 549. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Smolich, H. S. Cox, and M. D. Esler Contribution of lungs to desipramine-induced changes in whole body catecholamine kinetics in newborn lambs Am J Physiol Regulatory Integrative Comp Physiol, January 1, 1999; 276(1): R243 - R250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Eisenhofer, B. Rundqvist, and P. Friberg Determinants of cardiac tyrosine hydroxylase activity during exercise-induced sympathetic activation in humans Am J Physiol Regulatory Integrative Comp Physiol, March 1, 1998; 274(3): R626 - R634. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Johansson, B. Rundqvist, G. Eisenhofer, and P. Friberg Cardiorenal epinephrine kinetics: evidence for neuronal release in the human heart Am J Physiol Heart Circ Physiol, November 1, 1997; 273(5): H2178 - H2185. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Parker, G. E. Newton, J. S. Landzberg, J. S. Floras, and W. S. Colucci Functional Significance of Presynaptic {alpha}-Adrenergic Receptors in Failing and Nonfailing Human Left Ventricle Circulation, October 1, 1995; 92(7): 1793 - 1800. [Abstract] [Full Text]
|
|
|
|
|
|
G. W. Lambert, D. M. Kaye, J. Lefkovits, G. L. Jennings, A. G. Turner, H. S. Cox, and M. D. Esler Increased Central Nervous System Monoamine Neurotransmitter Turnover and Its Association With Sympathetic Nervous Activity in Treated Heart Failure Patients Circulation, October 1, 1995; 92(7): 1813 - 1818. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
